Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.

Area of Science:

• Clinical Trials Methodology
• Epidemiology
• Infectious Diseases

Background:

• Global health pandemics necessitate rapid identification of effective treatments and vaccines.
• Traditional clinical trial designs are often inefficient for pandemic response.
• Multi-arm multi-stage (MAMS) adaptive platform trials offer a solution for efficient intervention assessment.

Purpose of the Study:

• To provide an overview of the benefits of MAMS designs in the context of COVID-19.
• To highlight successes of MAMS trials during the COVID-19 pandemic.
• To discuss the importance of international collaboration in synthesizing trial results.

Main Methods:

• Utilizing a multi-arm multi-stage (MAMS) adaptive platform trial design.
• Simultaneously investigating multiple treatments against a shared control arm.
• Employing interim analyses to drop non-promising interventions and continue recruitment for effective ones.

Main Results:

• MAMS designs significantly speed up the identification of efficacious treatments.
• The approach allows for efficient testing of numerous interventions.
• Successful application of MAMS trials during the COVID-19 pandemic.

Conclusions:

• MAMS adaptive platform trials are highly effective for pandemic response.
• International collaboration and prospective data synthesis are crucial for faster clinical trial outcomes.
• Preparedness for future pandemics can be enhanced through efficient trial methodologies.